
Google has been fined US$500m (£306m) by the US government for allowing  online pharmacies in Canada to advertise unlicenced drugs to US  customers.
The fine, one of the largest forfeitures ever in the US, represents the  revenue received by the company as a result of Canadian pharmacies  advertising through Goggle’s AdWords programme, plus gross revenue made  by Canadian pharmacies from their sales to US customers.
The distribution of prescription drugs from pharmacies outside the US to  customers in the US breaches the Federal Food, Drug and Cosmetic Act  and the Controlled Substances Act.
The US Department of Justice (DoJ),  which led the investigation, said that while Canada has its own  regulatory rules for prescription drugs, Canadian pharmacies that ship  prescription drugs to US residents are not subject to Canadian  regulatory authority.
This means that many sell drugs obtained from countries other than  Canada that lack adequate pharmacy regulations, which could be dangerous  for US customers.
The DoJ said Google was aware as early as 2003 that it was illegal for  pharmacies to ship controlled and non-controlled prescription drugs into  the US from Canada, but had failed to take adequate action.
In fact from 2003 to 2009, the DoJ said that Google provided customer  support to some of these Canadian online pharmacy advertisers to assist  them in placing and optimising their AdWords advertisements, and in  improving the effectiveness of their websites.
‘This investigation is about the patently unsafe, unlawful, importation  of prescription drugs by Canadian online pharmacies, with Google’s  knowledge and assistance, into the US, directly to US consumers,’ said  US Attorney Peter Neronha.
‘It is about taking a significant step forward in limiting the ability  of rogue online pharmacies from reaching US consumers, by compelling  Google to change its behaviour.
‘It is about holding Google responsible for its conduct by imposing a  $500m forfeiture, the kind of forfeiture that will not only get Google’s  attention, but the attention of all those who contribute to America’s  pill problem.’
The Partnership for Safe Medicines, a non-profit organisation dedicated  to curbing counterfeit drugs, said the fine was a ‘welcome and long  overdue development’.
‘We are hopeful the Google settlement sends a clear message to other  large online advertising companies that this practice is dangerous and  in most cases leads to unlawful activity,’ the organisation said.
‘Illicit internet vendors, who often are no more Canadian than their  logo or IP address, ship consumers drugs that are at best not  FDA-approved and at worst lethal. For several years, they have escalated  use of social media channels to advertise to American consumers.
‘We are hopeful that this settlement will send a message to other online  advertisers that policies need to be in place to prohibit this type of  activity.’